The New Regulation (EU) 2017/745 for medical devices (MDRs), which went into effect on May 26, 2021, is a major update to the regulatory framework in the European Union (EU).
Today’s disruptive market scenarios, the unknown consequences of COVID-19, increasingly sophisticated personalized, and the new FDA and EU Regulatory implications…
The COVID-19 pandemic has disrupted global supply chains on a monumental scale, rushing all MD&D manufacturers to quickly re-adapt and respond to new challenging market scenarios.
Terumo Americas is a global leader in medical device industry manufacturing life-supporting and sustaining Class III devices across four divisions over the last 50 years, including interventional systems, injection and infusion therapy devices and drug delivery devices.
MicroPort CRM selected Opcenter MES control production and increase traceability. Read their story.
